INTERNATIONAL PATENT: CHANGCHUN GENESCIENCE PHARMACEUTICAL CO., LTD., 长春金赛药业有限责任公司 FILES APPLICATION FOR "IN-SITU SUBCUTANEOUS IMPLANTABLE FEMALE HORMONE MODULATION COMPOSITION, PREPARATION METHOD THEREFOR AND USE THEREOF"

GENEVA, June 22 -- CHANGCHUN GENESCIENCE PHARMACEUTICAL CO., LTD. (1718 Yueda Road, Changchun High-Tech Dev. ZoneChangchun, Jilin 130012), 长春金赛药业有限责任公司 (中国吉林省长春市高新区越达路1718号) filed a patent application (PCT/CN2024/138415) for "IN-SITU SUBCUTANEOUS IMPLANTABLE FEMALE HORMONE MODULATION COMPOSITION, PREPARATION METHOD THEREFOR, AND USE THEREOF" on Dec 11, 2024. With publication no. WO/2025/124422, the details related to the patent application was published on Jun 19, 2025.

Notably, the patent application was submitted under the International Patent Classifi...